| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
108.15(B) |
| Last
Volume: |
4,786,595 |
Avg
Vol: |
8,429,684 |
| 52
Week Range: |
$48.64 - $75.67 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
250,541 |
430,874 |
929,865 |
2,041,378 |
| Total Sell Value |
$18,359,902 |
$29,055,549 |
$55,374,067 |
$104,875,147 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
25 |
42 |
77 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dockendorff Charles J |
Director |
• • – |
2023-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,946 |
21,025 |
|
- |
|
| Roux David J |
Director |
• • – |
2023-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,946 |
73,591 |
|
- |
|
| Zane Ellen M |
Director |
• • – |
2023-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,946 |
45,629 |
|
- |
|
| Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
• • – |
2023-05-02 |
4 |
D |
$52.90 |
$49,303 |
D/D |
(932) |
24,150 |
|
- |
|
| Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
• • – |
2023-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,101 |
25,082 |
|
- |
|
| Sorenson John Bradley |
EVP, Global Operations |
• • – |
2023-05-02 |
4 |
D |
$52.90 |
$101,409 |
D/D |
(1,917) |
36,689 |
|
- |
|
| Sorenson John Bradley |
EVP, Global Operations |
• • – |
2023-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,203 |
38,606 |
|
- |
|
| Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2023-05-02 |
4 |
S |
$52.49 |
$4,377,543 |
D/D |
(83,401) |
12,269 |
|
-3% |
|
| Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2023-05-02 |
4 |
OE |
$12.89 |
$395,568 |
D/D |
30,688 |
95,670 |
|
- |
|
| Carruthers Wendy |
EVP, Human Resources |
• • – |
2023-04-17 |
4 |
AS |
$51.96 |
$606,423 |
D/D |
(11,671) |
83,373 |
|
-3% |
|
| Carruthers Wendy |
EVP, Human Resources |
• • – |
2023-04-17 |
4 |
OE |
$13.08 |
$94,954 |
D/D |
6,408 |
95,044 |
|
- |
|
| Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
• • – |
2023-04-05 |
4 |
AS |
$50.40 |
$247,111 |
D/D |
(4,903) |
78,673 |
|
2% |
|
| Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
• • – |
2023-03-23 |
4 |
AS |
$47.97 |
$321,543 |
D/D |
(6,703) |
22,981 |
|
6% |
|
| Carruthers Wendy |
EVP, Human Resources |
• • – |
2023-03-15 |
4 |
AS |
$47.60 |
$555,575 |
D/D |
(11,671) |
88,636 |
|
9% |
|
| Carruthers Wendy |
EVP, Human Resources |
• • – |
2023-03-15 |
4 |
OE |
$13.08 |
$94,954 |
D/D |
6,408 |
100,307 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2023-03-02 |
4 |
AS |
$46.66 |
$1,399,914 |
D/D |
(30,000) |
225,958 |
|
11% |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2023-03-01 |
4 |
AS |
$46.64 |
$3,526,337 |
D/D |
(75,610) |
255,958 |
|
12% |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2023-03-01 |
4 |
OE |
$13.08 |
$715,794 |
D/D |
45,610 |
331,568 |
|
- |
|
| Monson Jonathan |
SVP, Global Controller and CAO |
• • – |
2023-03-01 |
4 |
AS |
$46.66 |
$233,315 |
D/D |
(5,000) |
34,868 |
|
12% |
|
| Monson Jonathan |
SVP, Global Controller and CAO |
• • – |
2023-03-01 |
4 |
OE |
$12.89 |
$64,450 |
D/D |
5,000 |
39,868 |
|
- |
|
| Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
• • – |
2023-02-22 |
4 |
AS |
$46.10 |
$153,974 |
D/D |
(3,340) |
88,479 |
|
15% |
|
| Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
• • – |
2023-02-21 |
4 |
D |
$46.23 |
$88,900 |
D/D |
(1,923) |
220,277 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,895 |
222,200 |
|
- |
|
| Brown Vance R |
SVP, GC and Corp. Secretary |
• • – |
2023-02-21 |
4 |
D |
$46.23 |
$10,587 |
D/D |
(229) |
41,651 |
|
- |
|
| Brown Vance R |
SVP, GC and Corp. Secretary |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
779 |
41,880 |
|
- |
|
2527 Records found
|
|
Page 9 of 102 |
|
|
1.25 (1.68%) 
